Viewing Study NCT05817058


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2025-12-25 @ 10:14 PM
Study NCT ID: NCT05817058
Status: TERMINATED
Last Update Posted: 2025-07-23
First Post: 2023-03-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: First-in-Human Dose Escalation Study of AFM28 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Sponsor: Affimed GmbH
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module